Literature DB >> 6171963

The IgG autoantibody binding determinant appearing on senescent membranes residues on a 62000 MW peptide.

M M Kay.   

Abstract

Mechanisms by which macrophages recognize and remove senescent red blood cells (RBC) were investigated. Present evidence indicates that the antigen binding portion of immunoglobulin G (IgG) autoantibodies in normal serum selectively binds to senescent RBC in situ and initiates their removal by mononuclear phagocytes. IgG autoantibodies eluted from senescent RBC were conjugated to cyanogen bromide activated Sepharose 4B, and used to isolate and purify the IgG binding receptor. Sialoglycoprotein mixtures were processed with the senescent cell IgG affinity column. Gel electrophoresis of the bound material eluted from the column revealed a single band migrating with a molecular weight of approximately equal to 62000. This isolated peptide, but not the sialoglycoprotein mixture from which it was isolated, absorbed the phagocytosis inducing ability of IgG. Thus, the senescent cell antigen to which IgG binds, is a 62000 Dalton glycopeptide.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171963

Source DB:  PubMed          Journal:  Acta Biol Med Ger        ISSN: 0001-5318


  3 in total

1.  Adhesion and erythrophagocytosis of human senescent erythrocytes by autologous monocytes and their inhibition by beta-galactosyl derivatives.

Authors:  J Vaysse; L Gattegno; D Bladier; D Aminoff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 2.  Antigenicity, storage, and aging: physiologic autoantibodies to cell membrane and serum proteins and the senescent cell antigen.

Authors:  M M Kay; K Sorensen; P Wong; P Bolton
Journal:  Mol Cell Biochem       Date:  1982-11-26       Impact factor: 3.396

3.  Oxidation as a possible mechanism of cellular aging: vitamin E deficiency causes premature aging and IgG binding to erythrocytes.

Authors:  M M Kay; G J Bosman; S S Shapiro; A Bendich; P S Bassel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.